Clinical trials

A two-year trial involving 300 people in Guernsey will look at the impact of weight loss jabs.

Patients enrol in a Greater Manchester study into the long-term affect of the weight-loss drugs.

Researchers say people who had a particular type of stroke may play "a vital role" in future treatment.

Seventy-six people with low vitamin D levels are being recruited to take part in the study.

Brightwater Research says its drug Valoxydin could be used to stop the spread of some tumours.

Hundreds of patients from Hampshire and Dorset trial the Enlighten test for detecting cancer.

Harry Brown, 19, was diagnosed with leukaemia two years ago and did not respond to early treatment.